# A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals

> **NCT02568332** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 20 (actual)

## Conditions studied

- Hepatitis C Infection

## Interventions

- **BIOLOGICAL:** AdCh3NSmut1
- **BIOLOGICAL:** MVA-NSmut

## Key facts

- **NCT ID:** NCT02568332
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-21
- **Primary completion:** 2017-01-26
- **Final completion:** 2017-10-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-10-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02568332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02568332, "A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02568332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*